Oct 17 (Reuters) - Rani Therapeutics ( RANI ) said on
Friday it has agreed a deal to license an oral drug to Japan's
Chugai Pharmaceutical ( CHGCF ), with an option to extend it to
up to five drugs, potentially bringing the total deal value to
$1.09 billion.